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Noncanonical NF-B signaling is a prerequisite 
for the anlage of secondary lymphoid tissues 
(SLTs). Mice carrying lesions in elements of this 
pathway are often alymphoplastic (absence of 
lymph nodes) and lack the specific lymphoid 
organization in spleen and thymus (Weih and 
Caamaño, 2003). The notion that cell-mediated 
immunity commences exclusively in SLTs pro-
vides a tangible explanation for the immuno-
deficiency  of  alymphoplastic  mice.  Because  of 
their inability to generate germinal centers, alym-
phoplastic mice such as lymphotoxin- receptor–
deficient (LTR/), LT/, NIKaly/aly, and 
NIK/ animals are all defective in immuno-
globulin class-switch (Miyawaki et al., 1994; 
Banks et al., 1995; Shinkura et al., 1996; Fütterer 
et al., 1998). However, T cell responses and cell-
mediated immunity are severely reduced in   
NIKaly/aly mice when compared with other alym-
phoplastic mice (Greter et al., 2009).
NF-B–inducing kinase (NIK) is a key me-
diator  of  the  noncanonical  NF-B  pathway 
(Sun and Ley, 2008). It transduces signals from 
distinct members of the TNFR family and in-
duces  via  phosphorylation  of  IB-specific   
kinase  (IKK-) the cleavage of p100-RelB to 
p52-RelB, which then translocates as hetero-
dimer into the nucleus (Senftleben et al., 2001; 
Xiao et al., 2004). The activity of NIK is tightly 
regulated on several levels, generally using the 
TNFR-associated factors 2/3 (TRAF2/3), cyto-
solic  inhibitor  of  apoptosis  1  (cIAP1),  and 
cIAP2 (Varfolomeev et al., 2007; Vince et al., 
2007),  which  prevent  basal  activation  of  this 
pathway. The signal-induced activation of the 
noncanonical pathway results in the degrada-
tion of TRAF2 and TRAF3 and thus in the 
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The canonical NF-B pathway is a driving force for virtually all aspects of inflammation. 
Conversely, the role of the noncanonical NF-B pathway and its central mediator NF-B–
inducing kinase (NIK) remains poorly defined. NIK has been proposed to be involved in the 
formation of TH17 cells, and its absence in TH cells renders them incapable of inducing 
autoimmune responses, suggesting a T cell–intrinsic role for NIK. Upon systematic analysis 
of NIK function in cell-mediated immunity, we found that NIK signaling is dispensable 
within CD4+ T cells but played a pivotal role in dendritic cells (DCs). We discovered that 
NIK signaling is required in DCs to deliver co-stimulatory signals to CD4+ T cells and that 
DC-restricted expression of NIK is sufficient to restore TH1 and TH17 responses as well as 
cell-mediated immunity in NIK/ mice. When CD4+ T cells developed in the absence of 
NIK-sufficient DCs, they were rendered anergic. Reintroduction of NIK into DCs allowed 
developing NIK/ CD4+ T cells to become functional effector populations and restored the 
development of autoimmune disease. Therefore, our data suggest that a population of 
thymic DCs requires NIK to shape the formation of most  CD4+ T effector lineages 
during early development.
©  2011  Hofmann  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first   
six months after the publication date (see http://www.rupress.org/terms). After   
six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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NIKaly/aly mice is not connected to their lack of SLTs but that 
NIK activity is critical for cellular immune function (Greter 
et al., 2009). Cell-mediated immunity could be induced in 
the  total  absence  of  SLTs  when  splenectomized  NIKaly/aly 
mice were reconstituted with a WT hematopoietic system. 
However, cell-mediated immunity could not be induced in 
mice featuring normal SLTs but carrying the NIKaly/aly lesion 
only in hematopoietic cells (Greter et al., 2009). Although a 
critical function for NIK has been suggested specifically in   
T cells by several studies (Yamada et al., 2000; Matsumoto   
et al., 2002; Ishimaru et al., 2006; Sánchez-Valdepeñas et al., 
2006; Jin et al., 2009), the data presented in this study suggest 
that the loss of T cell function in NIKaly/aly mutants was not   
T cell intrinsic, but rather resulted from a defect in hemato-
poietic accessory leukocytes, namely DCs.
We show in this study that NIK-lesioned T cells were in-
deed capable of secreting effector cytokines and acquiring full 
effector functions, depending on the thymic environment in 
which they developed. Instead of a T cell–intrinsic lesion, loss 
of NIK in thymic DCs imprinted a long-lasting halt in T cell 
effector function. However, if NIK-deficient T cells matured 
within a thymic environment that hosts NIK, T cells gained 
proper effector functions regardless of their NIK deficiency. 
Thus, we propose that thymic DCs, which so far have only 
been  implemented  in  negative  selection  (Gallegos  and   
Bevan, 2004) and the induction of natural regulatory T cells   
(nTreg cells; Proietto et al., 2009), are capable of imprinting 
subsequent T cell effector function onto developing  thy-
mocytes. This  ability  of  thymic  DCs  is  strictly  dependent   
on NIK.
RESULTS
Loss of NIK function results in reduced T cell proliferation, 
differentiation, and production of effector cytokines
We have recently reported that NIKaly/aly mice are resistant to 
the induction of EAE because of the loss of function of NIK 
within the hematopoietic compartment and more specifically 
because of a defect in T cell priming, independent of the lack 
of SLTs (Greter et al., 2009). Furthermore, NIKaly/aly T cells 
have been reported to be defective in proliferation and secre-
tion of IL-17, IL-2, and GM-CSF (Matsumoto et al., 2002; 
Sánchez-Valdepeñas et al., 2006; Jin et al., 2009). In line with 
these previous studies, we observed that in vitro, polyclonally 
activated NIKaly/aly CD4+ T cells produced lower amounts of 
effector  cytokines  (IL-2,  IFN-,  and  IL-17)  than  hetero-
zygous NIKaly/+ controls, whereas the production of IL-4   
was unaffected (Fig. 1 A). This suggests a T cell intrinsic im-
pairment of polarization conferred by the ablation of NIK 
signaling. To further investigate the requirement of NIK for 
antigen-specific T cell activation, we crossed NIKaly/aly mice 
with TCR transgenic 2d2 mice, in which the TCR recog-
nizes the immunodominant epitope of the myelin oligoden-
drocyte glycoprotein (MOG35–55). As expected, NIKaly/aly-2d2 
T cells also failed to secrete effector cytokines upon encoun-
tering their cognate antigen (Fig. 1 B). To exclude the possibility 
that the observed defects were caused by the developmental 
stabilization of NIK protein (Liao et al., 2004). NIKaly/aly mice 
contain a point mutation that is located in the C-terminal   
region of NIK and is responsible for the physical interaction 
with the upstream TRAFs and IKK- (Shinkura et al., 1999). 
Thus, the levels of nuclear p52 in several tissues and cell types 
of NIKaly/aly mice are virtually ablated (Xiao et al., 2001b).
There  is  evidence  that  noncanonical  NF-B  signaling 
within hematopoietic cells is involved in several human dis-
eases  such  as  lymphoid  cancers,  including  EBV-positive 
Hodgkin’s lymphoma and HTLV-1–transformed T cell lym-
phoma (Xiao et al., 2001a; Atkinson et al., 2003; Eliopoulos   
et al., 2003). Also, mutations in NIK have been correlated with 
the development of multiple myeloma (Annunziata et al., 
2007). Thus, NIK poses an attractive pharmacological target 
for the treatment of a variety of diseases (Staudt, 2010), and it is 
thus important that its role and function within the immune 
system are resolved.
For many years, it has been believed that the noncanonical 
NF-B pathway is preferably activated by ligands either im-
portant for the lymphoid organogenesis (through LTR) or 
in B cell responses (through CD40 and BAFF-R; Youssef and 
Steinman, 2006). However, it has become increasingly evident 
that the noncanonical NF-B pathway can be triggered by 
many  different  ligands  such  as  RANK,  LIGHT, TWEAK, 
CD70, and CD28 (Darnay et al., 1999; Yin et al., 2001;   
Ramakrishnan et al., 2004; Sánchez-Valdepeñas et al., 2006; 
Nadiminty et al., 2007; Bhattacharyya et al., 2010; Maruyama 
et al., 2010; Sanz et al., 2010). Furthermore, it was reported 
that NIK can also signal into the classical NF-B pathway 
(Ramakrishnan  et  al.,  2004;  Zarnegar  et  al.,  2008;  Staudt, 
2010; Sasaki et al., 2011). The vast variety of triggers suggests 
that noncanonical NF-B signaling is not exclusively active 
in the development of SLTs but also plays a role in B and   
T cell responses as well as in the function of APCs. NIK-
deficient T cells have been shown to be defective in secretion 
of IL-2 and GM-CSF (Sánchez-Valdepeñas et al., 2006). They 
are further limited in their proliferative capacity as well as 
TH17 differentiation and fail to become pathogenic in exper-
imental autoimmune encephalomyelitis (EAE), graft versus 
host disease, and in models of transplantation (Yamada et al., 
2000; Matsumoto et al., 2002; Ishimaru et al., 2006; Sánchez-
Valdepeñas  et  al.,  2006,  2010;  Greter  et  al.,  2009;  Jin   
et al., 2009).
Apart from the involvement in T cell function, alternative 
NF-B signaling has been controversially discussed in the   
induction of central tolerance by regulating the development 
and  function  of  Aire+  medullary  thymic  epithelial  cells 
(mTECs; Chin et al., 2003; Kajiura et al., 2004; Venanzi et al., 
2007; Akiyama et al., 2008). The impaired mTEC function in 
NIKaly/aly or RelB-deficient mice provides a potential explana-
tion for the reported autoimmune phenotypes. However, the 
reason for disturbed cell-mediated immunity in NIKaly/aly 
animals remains poorly understood.
Even  though  the  immunodeficiency  in  NIKaly/aly  mice 
was thought to be caused by their alymphoplasia, we have previ-
ously reported that the defect in cell-mediated immunity in JEM Vol. 208, No. 9 
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(Fig.  1  D).  Upon  immunization  of 
those  mice  with  MOG35–55/CFA,   
NIKaly/aly-2d2 T cells further failed to re-
spond to their cognate antigen, whereas 
control NIKaly/+-2d2 T cells strongly 
expanded  (Fig.  1  E).  In  addition, 
Rag1/  mice  reconstituted  with   
T  cells  from  NIKaly/aly-2d2  → WT 
BMCs remained completely resistant 
to EAE, suggesting that NIKaly/aly-2d2 
T  cells  cannot  be  primed  by  NIK- 
sufficient accessory cells (Fig. 1 F). Col-
lectively, the data support the notion 
that NIK deficiency indeed leads to a T cell–intrinsic lesion.
Loss of NIK results in a primary APC defect
Our data and a previous study (Jin et al., 2009) support a   
T cell–intrinsic role of NIK in cell-mediated immunity. How-
ever, we further aimed to identify the role of NIK in the   
accessory cell compartment. BMCs were generated by trans-
ferring a 4:1 mixture of Rag1/ and NIKaly/aly-2d2 BM into 
Rag1/ mice. In those mice, NIKaly/aly-2d2 T cell progenitors 
are developing within an NIK-sufficient accessory cell envi-
ronment. Surprisingly, Rag1/ + NIKaly/aly-2d2 → Rag1/ 
BMCs  developed  EAE  comparable  with  NIKaly/+-2d2  → 
Rag1/ BMCs (Fig. 2 A). This finding demonstrates that 
NIK plays a vital role in hematopoietic accessory cells rather than 
in T cells to develop autoimmune inflammation. Complemen-
ting this result, polyclonally in vitro activated CD4+ T cells 
malformations of SLTs in NIKaly/aly mice, we generated BM 
chimeric mice (BMCs) in which WT mice were reconsti-
tuted with hematopoietic stem cells from either NIKaly/aly-
2d2 or NIKaly/+-2d2 mice. We found that even if most of the 
CD4+ T cells carry the cognate antigen-specific TCR, NIKaly/aly-
2d2  → WT  BMCs  retained  their  EAE  resistance  upon 
MOG35–55/CFA immunization (Fig. 1 C), emphasizing the 
critical role of NIK signaling for the development of T cell–
mediated autoimmune responses.
Because T cells from NIKaly/aly-2d2 → WT BMCs failed to 
acquire pathogenic properties, we addressed their behavior in 
antigen-independent homeostatic expansion in lymphopenic 
Rag1/ mice. After adoptive transfer of CD4+ T cells from 
NIKaly/aly-2d2  →  WT  BMCs  into  Rag1/  mice,  we   
observed a reduction in homeostatic expansion when com-
pared with CD4+ T cells from NIKaly/+-2d2 → WT BMCs 
Figure 1.  NIKaly/aly mice are resistant to 
EAE because of the lack of NIK signaling 
in immune cells. (A) CD4+ T cells of NIKaly/aly 
or NIKaly/+ mice were stimulated in vitro with 
plate-bound -CD3/-CD28 for 48 h. Cyto-
kine secretion was analyzed by ELISA.  
(B) Splenocytes from NIKaly/aly-2d2 or NIKaly/+-
2d2 mice were stimulated in vitro with 
MOG35–55 and -CD28 for 48 h. Cytokine  
secretion was analyzed by ELISA. (C) NIKaly/aly-
2d2 → WT or NIKaly/+-2d2 → WT BMCs were 
immunized with MOG35–55/CFA and monitored 
daily for clinical signs of EAE (n = 6).  
(D–F) CD4+ T cells from NIKaly/aly-2d2 → WT  
or NIKaly/+-2d2 → WT BMCs were transferred 
into Rag1/ mice. Homeostatic expansion 
was observed by analyzing the percentage of 
CD4+ T cells within total lymphocytes in the 
peripheral blood (D). 30 d after adoptive CD4+ 
T cell transfer, Rag1/ mice were immunized 
with MOG35–55/CFA and observed for antigen-
driven expansion by FACS analysis of blood at 
day 7 after immunization (E) and clinical signs 
of EAE (n = 6; F). Each graph shows one rep-
resentative of three independent experiments. 
(A, B, D, and E) Error bars indicate SD. *, P ≤ 
0.05. (C and F) Error bars indicate SEM.1920 Loss of NIK signaling in DCs prevents autoimmunity | Hofmann et al.
T cells, whereas the vast majority of DCs carry the mutated 
NIKaly/aly protein. To do so, a 1:1 mixture of CD11cDTR and 
NIKaly/aly BM was transferred into irradiated WT recipients 
(Fig.  4 A).  Upon  injection  of  DTx,  DCs  of  CD11cDTR  
origin (NIK+/+) were depleted, whereas mutant NIKaly/aly DCs 
were retained. The efficiency of DC ablation in CD11cDTR 
from Rag1/ + NIKaly/aly → WT BMCs were rescued in 
their ability to secrete IL-17 and IFN- (Fig. 2 B), suggesting 
that the production of effector cytokines by T cells requires 
intact NIK signaling in the accessory cell compartment but 
not the T cell compartment.
DC maturation and co-stimulation are dependent  
on NIK signaling
The most prominent accessory cells involved in the induction 
of cell-mediated immunity and antigen presentation are DCs. 
It has been reported that in vitro NIKaly/aly DCs have defects 
in the expression of CD80, CD86, and MHCII as well as in 
antigen presentation and their ability to drive T cell expan-
sion (Garceau et al., 2000; Tamura et al., 2006; Lind et al., 
2008). Also the ability of T cells to secrete effector cytokines 
is largely dependent on the capacity of APCs to provide T cell 
instructive  cytokines.  In  particular,  the  cytokines  IL-12,   
IL-23, and IL-6 have a major impact on the polarization of 
effector T cells. We investigated the ability of splenic NIKaly/aly 
DCs to secrete these factors after stimulation with anti-CD40, 
thereby mimicking T cell–APC interactions. Interestingly, ac-
tivated NIKaly/aly DCs secreted significantly lower levels of the 
proinflammatory cytokine subunit IL-12/IL-23p40 (Fig. 3,   
A and B; and Fig. S1, A and B). We could further observe a 
strong reduction of the transcripts for IL-12p35 and IL-23p19 
(Fig. S1 C) and protein levels of IL-6 (Fig. 3 C). These data 
suggest that NIK signaling in DCs upon DC–T cell inter-
action via CD40 is critical for the capacity of DCs to secrete   
T cell-instructive cytokines.
NIKaly/aly DCs are restrained in T cell priming  
and fail to induce EAE
To verify the reduced priming capacity of NIKaly/aly DCs in 
vivo,  we  established  a  model  based  on  diphtheria  toxin 
(DTx)–mediated cell ablation. We created mice with an immune 
compartment containing both NIK-deficient and -sufficient 
Figure 2.  Loss of NIK signaling in accessory cells determines the fate of T cells early in development. (A) Lethally irradiated Rag1/ mice were 
reconstituted with BM of NIKaly/aly-2d2, NIKaly/+-2d2, or a 4:1 mixture of Rag1/ and NIKaly/aly-2d2 mice. 6 wk after reconstitution, BMCs were immunized 
with MOG35–55/CFA and observed for clinical signs of EAE (n = 6). Error bars indicate SEM. (B) Lethally irradiated WT mice were reconstituted with BM of 
NIKaly/aly, NIKaly/+, or a 4:1 mixture of Rag1/ and NIKaly/aly mice. 6 wk after reconstitution, CD4+ T cells were isolated and stimulated with plate-bound  
-CD3/-CD28. Supernatants were analyzed by ELISA. Each graph shows one representative of three independent experiments. Error bars indicate SD.
Figure 3.  NIKaly/aly DCs are restrained in secretion of proinflam-
matory cytokines. (A–C) Splenic NIKaly/aly or control DCs were stimu-
lated in vitro with -CD40 and IFN- for 24 h. GolgiPlug was added 
for the last 4 h of culture. Intracellular anti–IL-12/IL-23p40 FACS 
staining was performed together with cell surface staining for CD11c 
(A). Supernatants were analyzed by ELISA for IL-12/IL-23p40 (B) and 
IL-6 (C). Each graph shows one representative of three independent 
experiments. (B and C) Error bars indicate SD.JEM Vol. 208, No. 9 
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hereafter called DCNIK). Upon further breeding those animals 
onto the NIK/ background, we generated mice that ex-
press NIKWT in DCs, whereas other cells and tissues lack the 
ability to express NIK. To verify the cell type–specific target-
ing of the NIKWT transgene, we analyzed GFP expression in 
different immune compartments, which confirmed the trans-
gene expression in DCs (Fig. S2 A).
To manipulate the expression of NIK only within the hema-
topoietic compartment and to provide a normal lymphoid organ 
structure, we again generated BMCs by transferring BM of   
either DCNIK-NIK/ or control DCNIK-NIK+/ and NIK/ 
mice into lethally irradiated WT mice. 6 wk after reconstitution, 
these BMCs were immunized with MOG35–55/CFA and ob-
served  for  the  development  of  clinical  disease.  Strikingly,   
DCNIK-NIK/ → WT BMCs were fully susceptible to EAE, 
even though most T cells are NIK/ (Fig. 5 A). Furthermore, 
the  secretion  of  proinflammatory  cytokines  IL-12/IL-23p40 
and IL-6 in DCs of DCNIK-NIK/ → WT BMCs was largely 
restored (Fig. 5 B). Also, the restoration of NIKWT in DCs res-
cued the secretion of T effector cytokines IL-17, IFN-, and 
GM-CSF (Fig. 5 C) after antigen restimulation. These findings 
demonstrate that NIK signaling in DCs is sufficient 
to generate autoaggressive CD4+ T cells, even if these 
T cells themselves do not express functional NIK.
In addition to verifying the transgene expres-
sion in DCs, we thoroughly analyzed other leuko-
cyte populations for inadvertent ectopic expression. 
Macrophages were found to be negative, and al-
though  microglia  can  express  transient  levels  of 
CD11c upon activation, they can be excluded as 
effectors in this model because NIK/ → WT 
BMCs have NIK-sufficient microglia but remained 
EAE resistant (Fig. 5 A). In DCNIK-NIK/ → WT 
mice was >90% (Fig. 4 B). We observed a significant delay   
in disease onset (Fig. 4 C) with decreased central nervous system 
(CNS) infiltration of T cells (Fig. 4 D), and particularly IL-17–
producing T cells (Fig. 4 E), in DTx-treated CD11cDTR +   
NIKaly/aly → WT BMCs compared with DTx-treated con-
trol  CD11cDTR  +  NIKaly/+  → WT  BMCs. This  finding 
strongly supports our previous in vitro (Fig. 3) and in vivo 
(Fig. 2 A) data and demonstrates that NIK signaling in DCs is 
critical for their ability to instruct T cell polarization and   
effector function.
Restoration of NIK signaling in DCs is sufficient to generate 
pathogenic T cells
To ascertain a primary role of NIK signaling in the DC com-
partment, we generated mice in which NIK expression is   
restricted to DCs. R26StopFLNIKWT mice express NIKWT 
preceded by a loxP-flanked neoR-Stop cassette and followed 
by an Frt-flanked IRES-eGFP within the ubiquitously active 
ROSA26 locus (Sasaki et al., 2008). Upon crossing to CD11c-cre 
mice, the neoR-Stop is excised, and NIKWT will be expressed 
in CD11c+ cells, which are mainly DCs (these mice are 
Figure 4.  Absence of NIK signaling in DCs signifi-
cantly delays EAE. (A) Lethally irradiated WT mice were 
reconstituted with a 1:1 mixture of CD11cDTR and NIKaly/aly 
or CD11cDTR and NIKaly/+ BM. Upon i.p. injection of DTx, 
CD11cDTR (NIK+/+) DCs are depleted, whereas NIKaly/aly or 
NIKaly/+ DCs remain. All other immune cells are still present 
as NIK+/+. (B) Efficiency of DC depletion in DTx-treated 
CD11cDTR mice was analyzed by flow cytometry.  
(C) CD11cDTR + NIKaly/aly → WT and CD11cDTR + NIKaly/+ → 
WT BMCs were immunized with MOG35–55/CFA and treated 
with DTx every second day. Mice were observed for clinical 
signs of EAE. Three individual experiments were pooled  
(n ≥ 15/group). Error bars indicate SEM. *, P ≤ 0.05.  
(D) FACS analysis of CNS-infiltrating lymphocytes in MOG35–55/
CFA-immunized DTx-treated CD11cDTR + NIKaly/aly → WT 
and CD11cDTR + NIKaly/+ → WT BMCs at peak disease (17 d 
after immunization). Several brains and spinal cords of 
each experimental group were pooled. (E) Splenocytes were 
isolated from MOG35–55/CFA-immunized DTx-treated/ 
untreated CD11cDTR + NIKaly/aly → WT and CD11cDTR + 
NIKaly/+ → WT BMCs and rechallenged in vitro with 50 µg/ml 
MOG35–55 peptide, followed by IL-17 ELISPOT. Triplicates  
of pooled splenocytes of one experiment are shown  
(n ≥ 5/group). Error bars indicate SD.1922 Loss of NIK signaling in DCs prevents autoimmunity | Hofmann et al.
DCs (cDCs; CD11c+CD172+ and CD172, respectively) 
and  plasmacytoid  DCs  (pDCs;  CD11cintCD45RA+),  were 
found  in  comparable  numbers  in  NIKaly/aly  and  NIKaly/+ 
mice (Fig. 6 A). However, both cDCs and pDCs in NIKaly/aly 
mice expressed reduced levels of CD80 and CD86 and 
even more drastically MHCII (Fig. 6 B), with the strongest re-
duction in the resident DC subset. This indicates some degree 
of functional impairment of APC properties, which we further 
assessed by co-culturing NIKaly/aly and NIKaly/+ thymic DCs 
with 2d2 CD4+ single-positive (SP) thymocytes in the pres-
ence of MOG35–55. NIKaly/aly thymic resident DCs elicited re-
duced proliferation in 2d2 CD4+ SP thymocytes (Fig. 6 C).
To  further  investigate  the  phenotypic  properties  of   
NIKaly/aly thymic DCs, we performed quantitative RT-PCR 
(qRT-PCR) analysis for various chemokine ligands and re-
ceptors  involved  in  thymic  DC  function  (Proietto  et  al., 
2008a). NIKaly/aly thymic DCs revealed a strong reduction in 
the expression of CCL17, CCL19, and CCL21 (Fig. 6 D), 
which are crucial for the migration of developing thymocytes 
(Ueno et al., 2004; Proietto et al., 2008a). Furthermore, the 
analysis of chemokine receptors revealed an overall reduction 
in the levels of CCR2, CCR5, CCR6, and CCR7 but in-
creased expression of CCR9 and TLR9 (Fig. S3). Collectively, 
BMCs, we detected a minor percentage of GFP+CD4+ and 
CD8+ T cells (Fig. S2 A). To ensure that this population of 
NIK-expressing T cells does not contribute to the EAE sus-
ceptibility of DCNIK-NIK/ → WT BMCs, we further bred 
TNIK-NIK/  mice  by  crossing  R26StopFLNIKWT  mice  to 
CD4-cre  and  NIK/  mice. TNIK-NIK/  → WT  BMCs 
were, similar to NIK/ → WT BMCs, completely EAE re-
sistant (Fig. S2 B). Thus, the reintroduction of NIKWT into the 
DC pool fully restored EAE susceptibility.
Loss of NIK signaling critically impairs thymic DC function
Our data thus far clearly showed that NIK signaling in DCs is 
critical for T effector function. However, if the restoration of 
NIK signaling in DCs alone reinstates T effector function, the 
fact that adoptively transferred mature NIKaly/aly T cells into 
NIK-sufficient recipients fail to acquire effector function rep-
resents a contradiction (Fig. 1). Thus, we hypothesized that 
NIK signaling in thymic DCs is required to enable develop-
ing thymocytes to exit the thymus as fully functional T cells. 
Therefore,  the  thymic  DC  compartment  of  NIKaly/aly  and   
NIKaly/+ mice was analyzed in detail. All three thymic DC 
subsets (Wu and Shortman, 2005; Proietto et al., 2008a;   
Li et al., 2009), namely migratory and resident conventional 
Figure 5.  Expression of NIK in DCs is sufficient to restore EAE susceptibility in NIK/ mice. (A) DCNIK-NIK/ → WT, DCNIK-NIK+/ → WT, and 
NIK/ → WT BMCs were immunized with MOG35–55/CFA and observed for clinical signs of EAE. Shown is one representative of three independent experi-
ments (n = 6). Error bars indicate SEM. (B) Splenic DCs were isolated from DCNIK-NIK/ → WT and DCNIK-NIK+/ → WT BMCs and stimulated in vitro with 
-CD40 and IFN- for 24 h. IL-12/IL-23p40 and IL-6 secretion was measured by ELISA. (C) Splenocytes of MOG35–55/CFA-immunized DCNIK-NIK/ → WT 
and DCNIK-NIK+/ → WT BMCs were isolated at the peak of disease and restimulated in vitro with MOG35–55 for 48 h. Supernatants were analyzed by 
ELISA. (B and C) Each graph shows one representative of three independent experiments. Error bars indicate SD.JEM Vol. 208, No. 9 
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expression of NIKaly/aly T cells, we speculated whether the ob-
served decrease of natural occurring nTreg cells in NIKaly/aly 
thymi is the result of altered licensing of T cells during their 
development. Recently, thymic T cell lineage commitment 
has been expanded to other lineages including TH17 cells 
(Marks et al., 2009). Therefore, we analyzed the gene expres-
sion of lineage-specific transcription factors in CD4+ SP cells 
of NIKaly/aly thymi (Fig. 7 C) and spleens (Fig. 7 D) and found 
that in addition to Foxp3, the expression of RORt and Tbet 
was decreased, whereas GATA3 was not affected. We further 
found that the percentage of IL-17– and IFN-–producing 
CD4+ SP thymocytes was strongly reduced in naive NIKaly/aly 
mice (Fig. 7 E). Interestingly, a very recent study described that 
RelB, which is one of the target molecules of NIK, is essential 
for LTR-dependent thymic commitment of  T cells   
toward IL-17 production (Powolny-Budnicka et al., 2011).   
we found that NIKaly/aly thymic DCs are phenotypically and 
functionally distinct from those in NIKaly/+ mice, suggesting a 
causative link between the altered function of thymic DCs 
and the subsequent loss of T effector function.
Restoration of NIK in DCs rescues Foxp3, RORt, and Tbet 
expression in developing thymocytes
Thymic DCs have primarily been implicated in mediating 
negative selection (Gallegos and Bevan, 2004). However, there 
is increasing evidence that thymocyte development not only 
selects the T cell receptor repertoire but also imprints effector 
function onto thymic emigrants. In particular, NIK has been 
suggested to be involved in the expansion of CD25+CD4+  
T cells (Lu et al., 2005; Tamura et al., 2006). We found a 50% 
reduction in FoxP3+ Treg cells in both developing and mature 
T cells (Fig. 7, A and B). Given the reduced effector cytokine 
Figure 6.  NIKaly/aly thymic DCs show reduced APC capacity. (A) Flow cytometric analysis of thymic DC subsets from NIKaly/aly and control animals. 
pDCs are CD11cintCD45RA+, thymic resident DCs are CD11c+CD172a, and thymic migratory DCs are CD11c+CD172a+. Numbers in the plots indicate the 
percentage of the respective DC subset of the total thymic DC fraction. (B) Expression analysis of MHCII, CD80, and CD86 on thymic DC subsets. Dotted 
lines represent heterozygous control DCs, solid lines NIKaly/aly DCs, and gray histograms unstained controls. (C) Proliferation of CFSE-labeled 2d2 CD4+  
SP thymocytes after 3 d of co-culture with thymic migratory (left) and resident (right) DCs in the presence of 10 µg/ml MOG35–55. Dotted lines represent 
CFSE profile after stimulation with heterozygous control DCs, solid lines show NIKaly/aly DCs, and gray histograms show unstimulated cells. (D) RNA of 
FACS-sorted thymic DC subsets from NIKaly/aly and NIKaly/+ mice was transcribed into cDNA and analyzed by qRT-PCR for expression of different chemo-
kines. Shown is the fold change in expression level compared with CD172 NIKaly/aly cDCs, which was set to 1. Data in all panels are representative of 
three independent experiments. Error bars indicate SD.1924 Loss of NIK signaling in DCs prevents autoimmunity | Hofmann et al.
DISCUSSION
NIK is widely held as a central mediator of noncanonical 
NF-B signaling and the activation of NF-B2. Indeed, both 
NF-B2/ and NIKaly/aly mice show impaired T and B cell 
responses, while displaying lymphocyte infiltration into vari-
ous organs similar to that of Aire/ mice (Anderson et al., 
2002; Liston et al., 2003; Kajiura et al., 2004; Zhu et al., 2006). 
However,  the  autoimmune  phenotype  in  NIKaly/aly  and   
NF-B2/ mice seems to originate from the stromal com-
partment, as transplantation of NIKaly/aly or NF-B2/ thymi 
into WT mice was sufficient to induce the breakdown in self-
tolerance, which is mediated by the loss of Aire 
function in mTECs (Kajiura et al., 2004; Zhu et al., 
2006). In contrast, the impairment of T cell re-
sponses in NIKaly/aly mice resulted from disrupted 
NIK signaling in hematopoietic cells (Greter et al., 
2009). Also, NIKaly/aly mice have a defect in the 
generation of Treg cells, which is not observed in 
NF-B2/ mice (Zhu et al., 2006). These and 
other  observations  (Ramakrishnan  et  al.,  2004; 
Speirs et al., 2004; Zarnegar et al., 2008; Sasaki   
et al., 2011) suggest that the signaling cascade by 
which NIK executes its function in cell-mediated 
immunity  may  not  be  exclusive  to  the  p52- 
dependent noncanonical NF-B pathway.
As it was widely believed that NIK signaling is 
predominately involved in the formation of SLTs, 
the apparent immunodeficiency of the NIKaly/aly 
strain was held as evidence for the requirement of 
SLTs in the formation of cell-mediated immunity 
(Hofmann et al., 2010). In recent years, it has how-
ever  become  evident  that  NIK  signaling  is  also   
applied by other cell types such as B cells, osteo-
clasts, cancer cells, and also by DCs and T cells, 
suggesting a role of noncanonical NF-B signal-
ing in adaptive immune responses (Matsumoto   
et al., 2002; Ishimaru et al., 2006; Tamura et al., 
2006; Lind et al., 2008; Greter et al., 2009; Jin et al., 
2009). We have recently shown that the inability 
In line with this, our observations suggest that thymic com-
mitment toward the TH1 or TH17 lineage might also occur for 
 T cells and that NIK signaling in thymic DCs is crucial for 
this process.
To verify that DC-restricted expression of NIKWT is capable 
of restoring early lineage commitment, we again generated DC-
NIK-NIK/ → WT, DCNIK-NIK+/ → WT, and NIK/ → 
WT BMCs and analyzed the expression of transcription factors 
in CD4+ SP thymocytes. As shown in Fig. 8 (A and B), DC- 
restricted NIKWT expression fully restored RORt, Tbet, and also 
Foxp3 expression in CD4+ SP thymocytes.
Figure 7.  NIKaly/aly mice show strongly reduced per-
centage of thymic committed nTreg cells and TH17 and 
TH1 cells. (A and B) NIKaly/aly and NIKaly/+ thymocytes and 
splenocytes were stained intracellularly for FoxP3 expression. 
Plots are gated on CD4+ CD8 cells (A). Shown are means of 
three mice each (B). (C and D) RNA of FACS-sorted SP CD4+ 
thymic (C) and splenic (D) T cells of NIKaly/aly and NIKaly/+ mice 
was transcribed into cDNA and analyzed by qRT-PCR for 
expression of RORt, Tbet, and GATA3. Shown is fold change 
of expression levels compared with one of three NIKaly/aly 
samples, which was set to 1. Data are representative of three 
independent experiments (n = 3). (E) NIKaly/aly and NIKaly/+ 
CD4+ SP thymocytes of naive mice were stimulated in vitro 
with PMA and ionomycin and stained intracellularly for the 
secretion of IL-17 and IFN-. Data are pooled from two in-
dependent experiments (n = 7). (B–E) Error bars indicate SD. 
*, P ≤ 0.05.JEM Vol. 208, No. 9 
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NIK-expressing T cells could potentially be involved in the 
rescue of immune function in DCNIK-NIK/ → WT BMCs. 
However, this is most unlikely because (a) we did not observe   
a preferential accumulation of NIK-expressing GFP+ T cells 
in the inflamed CNS at peak disease in DCNIK-NIK/ → 
WT  BMCs  (not  depicted),  (b) T  cell  function  of  mixed 
Rag1/ + NIKaly/aly → Rag1/ BMCs was fully restored 
even though the entire T cell compartment was NIK defi-
cient, and (c) the transgenic expression of NIKWT in T cells of 
TNIK-NIK/-2d2 → WT BMCs did not render mice EAE 
susceptible (Fig. S2 B). However, preliminary data suggested 
that ectopic expression of NIKWT in TNIK mice might affect 
additional aspects of T cell function.
Interestingly, adoptively transferred adult NIKaly/aly T cells 
failed  to  acquire  pathogenicity  but  rather  displayed  an   
anergy-like state, although they were primed by NIK-sufficient 
accessory cells (Fig. 1). Only upon undergoing thymic devel-
opment  in  the  presence  of  NIK-sufficient  accessory  cells 
could CD4+ T cells give rise to pathogenic effector cells. This 
suggests that against current belief, NIK is largely dispensable 
within T cells. In contrast, we suggest that the anergic T cell 
phenotype observed in NIKaly/aly and NIK/ mice is caused 
by defective T cell development caused by dysfunctional thy-
mic DCs. We therefore propose that NIK signaling is critical 
in DCs to license T cells during thymic development and 
avoid anergy.
A  role  for  noncanonical  NF-B  signaling  in  DCs  has   
already been suggested, but the precise impact on T cell func-
tion has not been addressed before. Although it was claimed 
that CD40-mediated activation of DCs is not dependent on 
NIK (Garceau et al., 2000; Yamada et al., 2000; Andreakos   
et al., 2003), others have demonstrated that peripheral NIKaly/aly 
DCs show reduced APC capacity, which results in diminished 
T  cell  proliferation  (Tamura  et  al.,  2006).  Furthermore,   
NIKaly/aly DCs showed a decreased ability to induce the expan-
sion of CD25+ CD4+ T cells in vitro (Tamura et al., 2006) and 
were unable to cross-prime CD8+ T cells to exogenous anti-
gen, involving multiple defects in antigen-processing path-
ways (Lind et al., 2008).
We  demonstrate  that  splenic  NIKaly/aly  DCs  produced 
lower levels of IL-12, IL-23, and IL-6. Furthermore, we show 
that NIKaly/aly DCs were hampered in the priming of CD4+ 
autoreactive T cells in vivo (Fig. 4). However, the relevance of 
NIK signaling in thymic DCs has until now not been ad-
dressed, most likely because of the incomplete understanding 
of the function of thymic DCs in general.
Currently, three phenotypically distinct thymic DC sub-
sets have been described, namely pDCs, CD172+CD11b+ 
CD8/lo migratory cDCs, and CD172CD11bCD8hi 
thymic resident cDCs (Wu and Shortman, 2005). One im-
portant function of thymic DCs appears to be negative selec-
tion at the CD4+ SP stage in T cell development (Brocker   
et al., 1997; Dakic et al., 2004; Gallegos and Bevan, 2004;   
Bonasio et al., 2006). In this context, death caused by high-
affinity interaction or by no interaction (death by neglect) 
is not the only fate of developing thymocytes, but also the 
of NIKaly/aly mice to mount cell-mediated immunity is in-
dependent of the developmental lymphoreticular malfor-
mations but a result of the interrupted NIK signaling in 
hematopoietic cells (Greter et al., 2009). Yet the mechanis-
tic consequences of lesioned NIK signaling in DCs and   
T cells remained poorly understood or might have been 
wrongly interpreted.
Recently, it was reported that NIK/ T cells adoptively 
transferred into Rag2/ mice failed to develop encephalito-
genic properties and to secrete proinflammatory cytokines 
(Jin et al., 2009). The authors concluded that NIK/ T cells 
are intrinsically defective and that NIK signaling in T cells is 
vital for the acquisition of an effector phenotype. This as-
sumption is corroborated by a previous study showing that 
NIKaly/aly T cells secrete reduced levels of IL-2 and GM-CSF 
(Matsumoto et al., 2002). Indeed, we confirmed a reduction 
in the secretion of proinflammatory cytokines by NIKaly/aly  
T cells and their failure to homeostatically expand. In addi-
tion we found that NIKaly/aly T cells were anergic toward their 
cognate antigen and thus failed to acquire pathogenic proper-
ties in the context of autoimmune disease. However, our ob-
servation that T cell function was impaired as a result of the 
loss of NIK in hematopoietic accessory cells and more specif-
ically in DCs challenges the concept of a T cell–intrinsic de-
fect in NIKaly/aly mice. Three independent experimental setups 
demonstrated that the T cell defects were the result of a DC-
intrinsic utilization of NIK: first, the presence of NIKaly/aly 
DCs together with WT T cells in vivo was sufficient to signif-
icantly diminish EAE development (Fig. 4); second, NIK/ 
T cells could differentiate into fully functional, autoaggressive 
T cells when NIK was restored in accessory cells only (Fig. 2); 
and third, when the expression of NIK was transgenically re-
stricted  to  DCs  via  the  CD11c  promoter,  cell-mediated   
immunity was fully restored even if T cells were NIK/ (Fig. 5). 
One caveat is that CD11c-Cre was also active in a small   
population of T cells. This small population of transgenic 
Figure 8.  Restoration of NIK in DCs rescues Foxp3, RORt, and 
Tbet expression in developing thymocytes. (A and B) DCNIK-NIK/ → 
WT, DCNIK-NIK+/ → WT, and NIK/ → WT BMCs were generated. Per-
centage of FoxP3+ cells in the thymi (A) and transcript levels of RORt, 
Tbet, and GATA3 in FACS-sorted CD4+GFP SP thymocytes (B) were ana-
lyzed. Shown is fold change of expression levels compared with one of 
three NIK/ → WT samples, which was set to 1. Data are representative 
of two independent experiments (n ≥ 3). Error bars indicate SD. *, P ≤ 0.05.1926 Loss of NIK signaling in DCs prevents autoimmunity | Hofmann et al.
expression of effector cytokines and the proportion of nTreg cells (Fig. S4). 
2d2 (MOG-TCR transgenic) mice were provided by  V. Kuchroo (Harvard Med-
ical School, Boston, MA). CD11cDTR mice were provided by S. Jung   
(Weizmann Institute of Science, Rehovot, Israel). CD11c-cre mice were provided 
by B. Reizis (Columbia University, New  York, NY). R26StopFLNIKWT and all 
other mice were maintained under specific pathogen-free conditions.
BMCs  were  generated  as  described  previously  (Becher  et  al.,  2002, 
2003). In brief, mice were lethally irradiated with a split dose of 1,100 rad. 
Femur, tibia, and pelvis of donor animals were flushed with PBS to obtain 
BM stem cells. 10 × 106 cells were injected i.v. per mouse. Mice were treated 
with 0.2% BORGAL in drinking water for 3 wk to prevent bacterial infec-
tions. All experiments involving animals were approved by the Swiss Can-
tonal Veterinary Office (13/2006, 55/2009; Zurich, Switzerland).
Induction of EAE and DTx treatment. EAE was induced as described 
previously (Gutcher et al., 2006; Gyülvészi et al., 2009). In brief, mice were 
immunized s.c. with 200 µg MOG35–55 (MEVGWYRSPFSRVVHLYRNGK; 
GenScript) emulsified in CFA (Difco) and two i.p. injections of 200 ng per-
tussis toxin on days 0 and 2. BMCs did not receive pertussis toxin. For EAE 
experiments with DTx treatment, mice were injected i.p. with 400 ng DTx 
(EMD) 1 d before immunization and then 200 ng DTx every second day for 
the entire length of the experiment.
Isolation of splenic DCs and in vitro stimulation. Spleens were re-
moved under sterile conditions. Each spleen was injected with a cocktail of 
1 mg/ml Liberase and 0.5 mg/ml DNaseI (Roche) in medium and incu-
bated at 37°C for 20 min. Single cell suspensions were prepared by homoge-
nizing  the  tissue  between  glass  slides  and  filtering  through  70-µm  cell 
strainers  followed  by  erythrocyte  lysis.  Splenic  DCs  were  isolated  with 
CD11c+ positive magnetic selection according to the manufacturer’s instruc-
tions (Miltenyi Biotech).
DCs were plated at a concentration of 106 cells/ml in RPMI 1640 me-
dium supplemented with 10% FCS, 1% l-glutamine, and 1% penicillin-
streptavidin (Invitrogen) and stimulated for 6–24 h at 37°C and 5% CO2 
with  10  µg/ml  -CD40  (FGK  4.5;  BioXCell)  and  20  ng/ml  IFN-  
(PeproTech). Supernatants were analyzed for IL-6 and IL-12/IL-23p40 using 
ELISA according to the manufacturer’s instructions (BD).
Isolation of thymic DCs and in vitro co-culture assays. Thymic DCs 
were isolated as previously described (Wirnsberger et al., 2009). In brief, 
thymi  were  digested  in  IMDM  containing  2%  FCS,  25  mM  HEPES,   
0.4 mg/ml Collagenase D (Roche), and DNase for 40 min at 37°C. After-
ward, high-density cells were separated from low-density cells by using a dis-
continuous Percoll density gradient ( = 1.115 and  = 1.055; GE Healthcare). 
After removal from the gradient, cells were washed and stained with antibodies 
against CD11c, CD8, CD172a, and CD45RA, followed by sorting into mi-
gratory DCs (CD11c+CD172a+), resident DCs (CD11c+CD172a), and pDCs 
(CD11cintCD45RA+) on a FACSAria (BD). Purity was routinely >95%.
For in vitro culture, 20,000 DCs were cultured with 100,000 sorted and 
CFSE-labeled CD4+ thymocytes or peripheral T cells in the presence of   
10 µg/ml MOG35–55 and 10 ng/ml IL-7. Analysis was performed after 72 h   
of culture.
Peripheral CD4+ T cell purification, in vitro stimulation, and adop-
tive transfer. Splenocyte single cell suspensions were prepared as described 
in Isolation of splenic DCs and in vitro stimulation. CD4+ T cells were puri-
fied with CD4+ negative magnetic selection according to the manufacturer’s 
instructions (Miltenyi Biotech). The purity was routinely >95% as confirmed 
by flow cytometry.
For in vitro stimulations of splenic CD4+ T cells, 3 × 106 CD4+ T cells/
ml were cultured in RPMI 1640 medium supplemented with 10% FCS, 1% 
l-glutamine, and 1% penicillin-streptavidin. Polyclonal CD4+ T cell activation 
was performed with 5 µg/ml plate-bound -CD3 and -CD28 for 48 h. For 
antigen-specific CD4+ T cell activation, whole 2d2 splenocytes were stimu-
lated with 20 µg/ml MOG35–55 and 5 µg/ml soluble -CD28 for 48 h.   
generation  of  nTreg  cells  or  induction  of  anergic T  cells 
(Ramsdell et al., 1989; Ramsdell and Fowlkes, 1990; Bendelac, 
2004). The mechanistic underpinnings of these processes are up 
to today poorly understood. Although the effect of the com-
plete lack of DCs on T cell development and negative selec-
tion  is  discussed  controversially  (Birnberg  et  al.,  2008; 
Ohnmacht et al., 2009), a diverted function of thymic DCs is 
expected to have consequences on T cell development.
The expression of various chemokine receptors and che-
mokines in thymic DC subsets has been analyzed and com-
pared with expression profiles of splenic DCs (Proietto et al., 
2008a). We also profiled thymic DCs of NIKaly/aly mice and 
found strongly reduced gene expression of CCR2, CCR5, 
CCR6, and CCR7. It has been proposed that these chemo-
kine receptors are important for the localization and migra-
tion of DCs into lymphoid tissues in general including the 
thymus (Bonasio et al., 2006). We further observed a strong 
reduction in the expression of the chemokines CCL17, 
CCL19, and CCL21 in thymic DCs of NIKaly/aly mice, which 
are important for intrathymic migration of positively selected 
thymocytes from the cortex to the medulla (Ueno et al., 2004; 
Proietto et al., 2008a).
Thymic DCs have been proposed to induce FoxP3 ex-
pression  and  the  formation  of  nTreg  cells  (Proietto  et  al., 
2008b). Recently, it became evident that also other  T   
effector cell lineages such as TH17 cells can at least partially be 
licensed already during thymic development (Marks et al., 
2009). Of note, for  T cells, a similar commitment toward 
IL-17 or IFN- production has been shown previously   
(Ribot et al., 2009), and a very recent study suggested both 
RelA and RelB to be the critical factors for this process   
(Powolny-Budnicka  et  al.,  2011). We  found  that  thymic   
licensing of  CD4+ T effector lineages at least to a certain 
extent relies on the function of NIK and that the expression 
of NIKWT in DCs alone could rescue not only FoxP3 but also 
Tbet and RORt expression in developing NIK-deficient 
thymocytes. Therefore, we propose that NIK signaling in thy-
mic DCs is crucial to imprint developing T cells to subse-
quently acquire full effector capabilities and to avoid progression 
into an anergic state.
MATERIALS AND METHODS
Mice and BM reconstitution. C57BL/6 (WT) and Rag1/ mice were 
purchased from the Jackson Laboratory and bred in house. Alymphoplasia 
mice (Map3k14aly mice here depicted as NIKaly/aly) were obtained from Clea 
Laboratories and bred in house. NIK/ mice on 129Sv/Ev background 
were  provided  by  R.D.  Schreiber  (Washington  University  in  St.  Louis,   
St. Louis, MO) and bred onto C57BL/6 background in house for 10 genera-
tions. Both NIKaly/aly and NIK/ mice were maintained by heterozygous 
breedings. NIKaly/+ and NIK+/ mice are haplo-sufficient (Miyawaki et al., 
1994; Yanagawa and Onoé, 2006), justifying the use of heterozygous animals 
as littermate controls. Furthermore, NIKaly/aly and NIK/ mice are identical 
in several aspects of their structural and functional impairments (Yin et al., 
2001; Greter et al., 2009; Jin et al., 2009). In all breedings with CD4-cre and 
CD11c-cre as well as R26NIKWT mice, which are pure C57BL/6, we used 
NIK/ animals to avoid the usage of mixed genetic backgrounds. Nonetheless, 
to ensure consistency between the different strains used, we analyzed NIKaly/aly 
and NIK/ mice and heterozygous controls as well as NIK+/+ mice for   JEM Vol. 208, No. 9 
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